A pilot study of the feasibility of long-term human bone balance during perimenopause using a 41Ca tracer

Nuclear Instruments and Methods in Physics Research, Section B: Beam Interactions with Materials and Atoms

Volumn 259, Issue 1, 2007, Pages 796-800

  Hui, S K ^a,d   Prior, J ^b   Gelbart, Z ^c   Johnson, R R ^c   Lentle, B C ^b   Paul, M ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c TRIUMF   (Canada)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

41Ca tracer; Accelerator mass spectrometry (AMS); BMD; Osteoporosis; Perimenopause

Indexed keywords

CALCIUM; MASS SPECTROMETRY; PARTICLE ACCELERATORS; PHASE TRANSITIONS; TRACE ELEMENTS;

ACCELERATOR MASS SPECTROMETRY (AMS); MINERAL DENSITY; OSTEOPOROSIS; PERIMENOPAUSE;

ISOTOPES;

EID: 34248183622     PISSN: 0168583X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nimb.2007.02.003     Document Type: Article

References (34)

1. Parfitt A.M. Quantum concept of bone remodeling and turnover: implications for the pathogenesis of osteoporosis. Calc. Tiss. Res. 28 (1979) 1
2. Parfitt A.M. The coupling of bone formation to bone resorption: a critical analysis of the concept and of its relevance to the pathogenesis of osteoporosis. Metab. Bone Dis. Relat. Res. 4 (1982) 1
3. Nordin B.E.C., Horowitz M., Need A., and Morris H.A. Renal leak of calcium in post-menopausal osteoporosis. Endocrinology 41 (1994) 41
4. Matkovic V., Kostial K., Simonovic I., Buzina R., Brodarec A., and Nordin C. Bone status and fracture rates in two regions of Yugoslavia. Am. J. Clin. Nutr. 32 (1979) 540
5. Heaney R.P., Recker R.R., and Saville P.D. Menopause changes in calcium balance performance. J. Lab. Clin. Med. 92 (1978) 953
6. Aitken J.M., Hart D.M., Anderson J.B., Lindsay R., Smith D.A., and Speirs C.F. Osteoporosis after oophorectomy for non-malignant disease in premenopausal women. Brit. Med. J. 2 (1973) 325
7. Prior J.C. Perimenopause: the complex endocrinology of the menopausal transition. Endocr. Rev. 19 (1998) 397
8. Okano H., Mizunuma H., Soda M., Kagami I., Miyamoto S., Ohsawa M., Ibuki Y., Shiraki M., Suzuki T., and Shibata H. The long-term effect of menopause on postmenopausal bone loss in Japanese women: results from a prospective study. J. Bone Min. Res. 13 (1998) 303
9. Recker R., Lappe J., Davies K., and Heaney R. Characterization of perimenopausal bone loss: a prospective study. J. Bone Min. Res. 15 (2000) 1965
10. Santoro N., Rosenberg J., Adel T., and Skurnick J.H. Characterization of reproductive hormonal dynamics in the perimenopause. J. Clin. Endocrinol. Metab. 81 (1996) 1495
11. Prior J.C. The ageing female reproductive axis II: ovulatory changes with perimenopause. In: Chadwick D.J., and Goode J.A. (Eds). Endocrine Facets of Ageing (2002), John Wiley and Sons Ltd., Chichester, UK 172
12. Kirschbaum C., Schommer N., Federenko I., Gaab J., Neumann O., Oellers M., Rohleder N., Untiedt A., Hanker J., Pirke K.M., and Hellhammer D.H. Short-term estradiol treatment enhances pituitary-adrenal axis and sympathetic responses to psychosocial stress in healthy young men. J. Clin. Endocrinol. Metab. 81 (1996) 3639
13. Nagata C., Takatsuka N., Kawakami N., and Shimizu H. Weight change in relation to natural menopause and other reproductive and behavioral factors in Japanese women. Annal. Epidemiol. 12 (2002) 237
14. Tremollieres F.A., Pouilles J.M., and Ribot C. Vertebral postmenopausal bone loss is reduced in overweight women: a longitudinal study in 155 early postmenopausal women. J. Clin. Endocrinol. Metab. 77 (1993) 683
15. Heaney R.P., and Whedon G.D. Radiocalcium studies of bone formation rate in human metabolic bone disease. J. Clin. Endocrinol. Metab. 18 (1958) 1246
16. Cochran M., Neville A., and Marshall E.A. Comparison of bone formation rates measured by radiocalcium kinetics and double-tetracycline labeling in maintenance dialysis patients. Calcified Tissue Int. 54 (1994) 392
17. Paul M., Ahmad I., and Kutschera W. Zeits. Phys. A 340 (1991) 249
18. Elmore D., Bhattacharya M.H., Sacco-Gibson N., and Peterson D.P. Nucl. Instr. and Meth. B 52 (1990) 531
19. 41Ca tracing. Nucl. Instr. and Meth. B 92 (1994) 483
20. 41Ca AMS measurement at LLNL. Nucl. Instr. and Meth. B 99 (1995) 557561
21. 41Ca and accelerator mass spectrometry to monitor calcium metabolism in end stage renal disease patients. Clin. Chem. 51 (2005) 2095
22. Petit M.A., Prior J.C., and Barr S.I. Running and ovulation positively change cancellous bone in premenopausal women. Med. Sci. Sports Exerc. 31 (1999) 780
23. Prior J.C., Vigna Y.M., Schechter M.T., and Burgess A.E. Spinal bone loss and ovulatory disturbances. New Engl. J. Med. 323 (1990) 221
24. ICRP Publication 30, Supplement to Part 2, Pergamon, Oxford, 1980, p. 40.
25. Sharma P., and Middleton R. Nucl. Instr. and Meth. B 29 (1987) 63
26. 41Ca by accelerator mass spectrometry to quantitate small changes in individual human bone turnover rates. J. Assoc. Lab. Autom. 9 (2004) 99
27. 41Ca for measuring dietary perturbations of bone resorption, this Conference.
28. Heaney R.P., Recker R.R., and Ryan R.A. Urinary calcium in perimenopausal women: normative values. Osteoporos. Int. 9 1 (1999) 13
29. Recker R.R., Lappe J., Davies K., and Heaney R.P. Characterization of perimenopausal bone loss: a prospective study. J. Bone Miner. Res. 15 10 (2000) 1965
30. Weaver C.M., and Fleet J.C. D Vitamin requirements: current and future. Am. J. Clin. Nutr. 80 6 Suppl. (2004) 1735S
31. Review Erratum. Am. J. Clin. Nutr. 81 (2005) 729
32. 41Ca isotope in urine, serum, and saliva samples. Anal. Biochem. 332 1 (2004) 193
33. The WHO Study Group. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Geneva: World Health Organization, 1994.
34. Recker R.R., and Barger-Lux M.J. The elusive concept of bone quality. Curr. Osteoporos. Rep. 2 3 (2004) 97